You are here

Appendix 1. Committee and Board Member Profiles

a photograph of the NBA Board Members

NBA Board Members (left to right) Chris Brook PSM, Gayle Ginnane (Chair), Alison Street AO, Patti Warn, Paul Bedbrook and Lyn Beazley AO. Inset: Mark Cormack.

NBA Board Continuing Members

Ms Gayle Ginnane - chair

Ms Gayle Ginnane was CEO of the Private Health Insurance Administration Council, a government agency reporting to the Minister for Health and Ageing, with financial and regulatory responsibility for the private health insurance industry until May 2008 and has broad experience as a senior manager in an insurance and regulatory environment, and an in depth understanding of governance, risk management and finance.

Ms Ginnane has considerable experience as an independent director on a number of boards, both commercial and not for profit, in the voluntary, government and private sectors. As well as Chair of the NBA Board, Ms Ginnane is a councillor on the Australian Pharmacy Council and a director of Police Health. She has also contributed to a number of voluntary organisations at senior and Board levels including Scouts ACT, the Arthur Shakespeare Foundation for Scouting and the Community Living Project.

Ms Ginnane is a member of the Institute of Public Administration, a fellow of the Australian Institute of Company Directors and an affiliate member of the Institute of Actuaries of Australia.

Ms Ginnane was re-appointed Chair of the NBA Board in January 2017.

Mr Paul Bedbrook - financial expert

Mr Paul Bedbrook has had a connection with blood issues via his personal involvement with haemophilia for over two decades. He is the father of two adult sons with haemophilia. For much of this time Mr Bedbrook has been involved with the Haemophilia Foundation NSW (HFNSW) and the Haemophilia Foundation Australia (HFA). Mr Bedbrook is a past President of HFNSW and past Treasurer of HFA. He brings his personal experiences with blood issues to the Board as well as feedback from a community of individuals who rely on the blood and plasma products distributed to Australia's health services under the auspices of the NBA.

Professionally, Mr Bedbrook has had over 30 years of experience in financial services. His current roles include: Chairman of Zurich Financial Services Australia Ltd, Independent non-executive Director of Credit Union Australia (CUA) Ltd and Independent Chairman of ASX listed Elanor Investors Group.

Mr Bedbrook was a senior executive for over 20 years with the Dutch global banking, insurance and investment group, ING. Mr Bedbrook's early career was as an Investment Analyst and Investment Portfolio Manager at ING, and between 1987 and 1995, he was the General Manager Investments and Chief Investment Officer for the Mercantile Mutual (ING) Group in Sydney. In the decade to 2010, Mr Bedbrook was President and CEO of INGDIRECT Canada, CEO and Director of ING Australia and Regional CEO of ING Asia Pacific based in Hong Kong.

Mr Bedbrook has been a member of the NBA Board since May 2011 and was appointed to his current Board role as financial expert in August 2013. Mr Bedbrook is also a member of the NBA Audit Committee.

Adjunct Professor Chris Brook PSM - state and territory representative (large jurisdiction)

Professor Chris Brook was a senior executive in Victorian Health for 30 years, fulfilling both professional
(Chief Medical Officer and Director, Public Health) and management roles (Regional Director; Director Acute Health; Director Rural Health and Aged Care; and Executive Director Wellbeing, Integrated Care and Ageing).

Professor Brook has been part of blood and blood policy since 1988 and a national champion since the 1990s, including the several transformations in that time. He is especially proud of how treatment for people with haemophilia has utterly transformed in his time.

Professor Brook was re-appointed to the Board in January 2017.

Mr Mark Cormack - Australian Government representative

Mr Mark Cormack is responsible for strategic national health policy, portfolio strategies and international engagement at the Department of Health. His national program responsibilities include primary health, mental health, public hospital funding agreements and dental.

Mr Cormack has worked in and for the public healthcare sector for over 30 years in various capacities as a health professional, senior manager, policy maker, planner, agency head and industry advocate. He has a Bachelor of Applied Science (University of Sydney) and Master of Health Management (University of Wollongong).

Mr Cormack has had a number of senior roles in the public healthcare system, including Member of the Australian Health Ministers' Advisory Council (AHMAC), Chair of the AHMAC Health Policy Priorities Principal Committee and Board Director of National E-Health Transition Authority.

Prior to joining the Department of Health in February 2015, Mr Cormack was a Deputy Secretary in the then Department of Immigration and Border Protection (DIBP) responsible for managing and resolving the immigration status of people who do not have legal authority to be in Australia or who are in breach of their visa conditions. His group was also responsible for the onshore detention network, community detention, bridging visa program, and the Department's compliance and removals functions. In addition, he worked with other countries to implement offshore processing and refugee settlement. Mr Cormack was the Department's senior executive responsible for implementation of Operation Sovereign Borders.

Mr Cormack was appointed the first Chief Executive Officer of Health Workforce Australia (HWA) in January 2010. HWA was a Commonwealth Statutory Authority, established by the Council of Australian Governments which planned, funded, researched and delivered programs to enhance and develop Australia's health workforce.

From July 2006 to January 2010 Mr Cormack was Chief Executive of ACT Health.

Mr Cormack was re-appointed to the NBA Board in January 2017.

Ms Patricia (Patti) Warn - community representative

Trained originally as a secondary school teacher in Tasmania, Ms Warn was a social and political researcher for the ABC's Four Corners program in Sydney for several years before becoming a Ministerial Advisor in Canberra across social security, health, community services and immigration. Ms Warn organised national community consultations to inform policy development in reforming disability services, women's health, HIV/AIDS, Creutzfeldt-Jakob disease awareness and aged care.

Ms Warn was a member of the Commonwealth Immigration Review Tribunal for five years. In retirement Ms Warn was appointed to the NSW Ministerial Advisory Committee on Ageing and became an official visitor to mental health facilities under the NSW Mental Health Act. She served for seven years as a Board member of Uniting Care Ageing's Sydney region.

Ms Warn has been a lay member of the NSW Law Society's Professional Conduct Committee for over a decade and has represented consumer interests on committees of the Australian Commission on Safety and Quality in Health Care, Health Workforce Australia, the Australian Council on Health Care Standards and the Australian Health Practitioner Regulation Agency. She is on the Board of the Seniors Rights Service in Sydney.

Ms Warn's personal commitment to the NBA stems from her mother's life being saved by blood transfusions following a postpartum haemorrhage.

Ms Warn was appointed to the NBA Board as the community representative in August 2013.

New Members

Professor Lyn Beazley AO - state and territory representative (small jurisdiction)

After graduating from Oxford and Edinburgh Universities, Professor Lyn Beazley built an internationally renowned research team in neuroscience that focussed on recovery from brain damage, with much of her investigations undertaken as Winthrop Professor at the University of Western Australia. Currently Professor Beazley is Sir Walter Murdoch Distinguished Professor of Science at Murdoch University.

Professor Beazley was the Chief Scientist of Western Australia from 2006 to 2013, advising the WA Government on science, innovation and technology, as well as acting as an Ambassador for science locally, nationally and internationally. Professor Beazley chairs several boards including the Terrestrial Ecosystems Research Network and serves on others including the WA State Government's Technology and Industry Advisory Council, the Royal Institution Australia and the Western Australian Art Gallery Foundation. Professor Beazley was a Trustee of the Western Australian Museum from 1999 to 2006 and currently is Patron of the Friends of the Museum.

In 2009 Professor Beazley was awarded Officer of the Order of Australia and elected a Fellow of the Australian Academy of Technological Sciences and Engineering. In 2011 Professor Beazley was inducted into the inaugural Western Australian Women's Hall of Fame and was elected a Fellow of the Australian College of Educators and a Companion of Engineers Australia. Professor Beazley has worked to promote science, technology, engineering and mathematics to the community, especially to young people. In 2015 she was inducted into the Western Australian Science Hall of Fame and was also announced the 2015 WA Australian of the Year.

Professor Beazley was appointed to the NBA Board in January 2017.

Associate Professor Alison Street AO - public health expert

Professor Alison Street graduated in 1971 from Monash University with first class honours in medicine.

After completing postgraduate training in clinical and laboratory haematology in Melbourne and Sydney, Professor Street spent three years in clinical research in Boston. Professor Street returned to Melbourne to work with Monash University and Alfred Health in 1984, where she retired from the positions of Head of Laboratory Haematology and Haemostasis-Thrombosis (including Haemophilia) in 2012.

Professor Street's main professional interests were in haemostasis-thrombosis, transfusion medicine and teaching. During her tenure at Alfred Health, Professor Street was Chief Examiner in haematology for the Royal College of Pathologists of Australasia between 2001 and 2006, and President of the Haematology Society of Australia and New Zealand between 1996 and 1998.

Professor Street was a Board member with the World Federation of Hemophilia (WFH) between 2002 and 2012 (Vice-President Medical between 2008 and 2012) and a Board member of the Australian Red Cross Blood Service (the Blood Service) between 1998 and 2004.

Professor Street's other appointments are:

  • Clinical Adjunct Associate Professor in the Department of Immunology and Pathology, Monash University
  • Chair of the NBA Haemovigilance Advisory Committee, and
  • Member of the Steering Committee for the Asia-Pacific Haemophilia Working Group.

Professor Street received the Award of Officer in the Order of Australia in 2006 for services to haematology and the community of people with congenital bleeding disorders, and is an honorary life member of the Haematology Society of Australia and New Zealand, Australian Society of Thrombosis and Haemostasis and the Australian and New Zealand Society of Blood Transfusion.

Professor Street was appointed to the NBA Board in January 2017.

Audit Committee Chair

Mr Ken Barker

Until 2009 Mr Barker had some 42 years of experience in the New South Wales Government. He worked for New South Wales Health for 24 years where his last appointment was as Chief Financial Officer. He is now director of his own company, which specialises in financial management and provision of strategic advice, mainly to government agencies. He is also a member of a number of state government governance boards and of several New South Wales agency audit and risk committees.

Mr Barker has worked with the former New South Wales Blood Transfusion Service, and has made important contributions to many of the key decisions and events that have shaped the current Australian blood sector: the establishment of the Australian Red Cross Blood Service and the NBA; provision of national indemnity arrangements for blood and blood products; the Stephen Review of the Australian Blood Banking and Plasma Product Sector; and the 2008 KPMG business study of the Blood Service.

Mr Barker was appointed to the NBA Interim Board and has served as a full Board member since the inception of the NBA. He was reappointed in May 2011 and his term extended until August 2013. He served as Chair of the NBA Audit Committee between 2003 and 2007 and continued to serve as an Audit Committee member, until his appointment as Chair in October 2013.

HTML version of this annual report converted and prepared by XiNG Digital Pty Ltd.